Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question
Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2387-2389
DOI: 10.1016/j.jtha.2026.04.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Behnood Bikdeli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Heart and Vascular Institute, Mass General Brigham, Boston, Massachusetts, USA; Ha…. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Brigham and Women's Hospital, Heart and Vascular Institute, Mass General Brigham, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Thrombosis Research…
- Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell, New Hyde Park, New York, USA; Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA;…
Zitieren
APA
Bikdeli, B., & Spyropoulos, A. C. (2026). Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question. Journal of Thrombosis and Haemostasis, 24(7), 2387-2389. https://doi.org/10.1016/j.jtha.2026.04.010
Vancouver
Bikdeli B, Spyropoulos AC. Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question. Journal of Thrombosis and Haemostasis. 2026;24(7):2387-2389. doi:10.1016/j.jtha.2026.04.010
BibTeX
@article{Bikdeli2026,
author = {Bikdeli, Behnood and Spyropoulos, Alex C},
title = {Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {7},
pages = {2387--2389},
doi = {10.1016/j.jtha.2026.04.010}
}
EUVIMED